Pharmaceutical Retail Chain
Pharmaceutical Retail Chain

Pharmaceutical Retail Chain Comprehensive Study by Type (Retail Pharmacy, Hospital Pharmacy, Clinic Pharmacy, Home care Pharmacy, Others), Services (App/Website, On-Call), Medication (Injectable, Infusible, Others), Offerings (Ambulatory Care, Critical Care Pharmacy, Nutrition Support Pharmacy, Others) Players and Region - Global Market Outlook to 2027

Pharmaceutical Retail Chain Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Jun 2022 Edition 222 Pages 84 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Pharmaceutical Retail Chain Market?

A pharmaceutical retail chain means any pharmaceutical company which has multiple medical stores or pharmacies. Pharmacy retail is used to the sale of pharmaceutical products, which include over-the-counter (OTC) drugs and prescription drugs. Pharmacy retail stores also sell various FMCG products along with pharmaceutical products and their related services. Covid-19 has changed the definition of health to a predict-and-prevent model. An increase in demand for better quality healthcare and focus on wellness is now single-handedly driving up the growth of organized retail pharmacies

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledWalgreens Company (United States), CVS Health (United States), Walmart (United States), Rite Aid Corp (United States), WALGREENS BOOTS ALLIANCE (United States), Fortis Healthworld (India), The Kroger (United States), Humana Pharmacy Solutions (United States), Botanics (India) and Liz Earle (United Kingdom)


The market study is being classified by Type (Retail Pharmacy, Hospital Pharmacy, Clinic Pharmacy, Home care Pharmacy and Others) and major geographies with country level break-up.

The global pharmaceutical retail chain market is fragmented due to its benefits include an increase in the number of pharmacies, better access, lower unit costs, extensive health insurance contract, and lower costs due to economies of scale. So the players are focusing on investing in artificial intelligence tools to improve the service. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Pharmaceutical Retail Chain market throughout the forecasted period.

Walgreens Company (United States), CVS Health (United States), Walmart (United States), Rite Aid Corp (United States), WALGREENS BOOTS ALLIANCE (United States), Fortis Healthworld (India), The Kroger (United States), Humana Pharmacy Solutions (United States), Botanics (India) and Liz Earle (United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Kaiser Permanente (United States), Rite Aid Corporation (United States), Cigna/Express Scripts (United States) and Deep Healthcare Enterprises (India).

Segment Analysis
Analyst at AMA Research have segmented the market study of Global Pharmaceutical Retail Chain market by Type, Application and Region.

On the basis of geography, the market of Pharmaceutical Retail Chain has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Penetration of Health Insurance Highly Impacts the Growth of the Domestic Pharmaceuticals Sector
  • Increasing number of Pharmacies in the Urban Area
  • Increasing Demands due to the Awareness of Better Quality Health Care
  • Consumers Increasing Inclination towards the Healthcare

Market Trend
  • Technological Innovations in the Pharmaceutical Retail Chain
  • Enhancement in Medical Infrastructure

Restraints
  • Concerns related to Pharmaceutical fraud
  • Stringent regulation due to COVID-19

Opportunities
  • Enhancement of Service towards customers' Holistic Wellness
  • Implantation of the Artificial intelligence tools to Improve the Pharmaceutical Retail Chain
  • Rising Opportunity from Generic Pharmaceuticals

Challenges
  • Lack of Transparency
  • Lack of Proper Regulation and Supervision


Market Leaders and some development strategies
On 14th July 2021, Eli Lilly announced the acquisition of Promoter Technologies, a private Biotech company. Promoter Technologies enables the development of therapeutic peptides and proteins with tunable activity that can be controlled using small molecules. Promoter Technology's glucose-sensing insulin program which is based on proprietary molecular engineering of protein sensors platform shows significant promise and Lilly is excited to enhance the diabetic pipeline with the company’s innovative technology.
On 8th March 2022, Toyota Tsusho Corporation announced an acquisition of 30% shares in Goodlife Pharmacies which is East Africa’s leading retail African pharmacy chain. This acquisition makes Toyota Tsusho Corporation's first entry into the retail pharmacy industry in Africa. Toyota Tsusho Corporation further contributes in Goodlife Pharmacies to improving access to high-quality pharmaceuticals in east Africa and Toyota Tsusho seeks to contribute to the improvement of healthcare outcomes on the African continent


Key Target Audience
Pharmaceutical Retail Chain, New Entrants, Regulatory Bodies, Potential Investors, Research and Development Institutes and Others

Frequently Asked Questions (FAQ):

1. Which factors would majorly drive the Pharmaceutical Retail Chain Market?
"Increased Penetration of Health Insurance Highly Impacts the Growth of the Domestic Pharmaceuticals Sector " is seen as one of major growth factors of Pharmaceutical Retail Chain Market in years to come.

2. Can we have customized study for Pharmaceutical Retail Chain Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. Which region will lead the Global Pharmaceutical Retail Chain Market?
United States will lead Pharmaceutical Retail Chain Market in coming years.
Report Objectives / Segmentation Covered
By Type
  • Retail Pharmacy
  • Hospital Pharmacy
  • Clinic Pharmacy
  • Home care Pharmacy
  • Others
By Services
  • App/Website
  • On-Call

By Medication
  • Injectable
  • Infusible
  • Others

By Offerings
  • Ambulatory Care
  • Critical Care Pharmacy
  • Nutrition Support Pharmacy
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Penetration of Health Insurance Highly Impacts the Growth of the Domestic Pharmaceuticals Sector
      • 3.2.2. Increasing number of Pharmacies in the Urban Area
      • 3.2.3. Increasing Demands due to the Awareness of Better Quality Health Care
      • 3.2.4. Consumers Increasing Inclination towards the Healthcare
    • 3.3. Market Challenges
      • 3.3.1. Lack of Transparency
      • 3.3.2. Lack of Proper Regulation and Supervision
    • 3.4. Market Trends
      • 3.4.1. Technological Innovations in the Pharmaceutical Retail Chain
      • 3.4.2. Enhancement in Medical Infrastructure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Retail Chain, by Type, Services, Medication, Offerings and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Retail Chain (Value)
      • 5.2.1. Global Pharmaceutical Retail Chain by: Type (Value)
        • 5.2.1.1. Retail Pharmacy
        • 5.2.1.2. Hospital Pharmacy
        • 5.2.1.3. Clinic Pharmacy
        • 5.2.1.4. Home care Pharmacy
        • 5.2.1.5. Others
      • 5.2.2. Global Pharmaceutical Retail Chain by: Services (Value)
        • 5.2.2.1. App/Website
        • 5.2.2.2. On-Call
      • 5.2.3. Global Pharmaceutical Retail Chain by: Medication (Value)
        • 5.2.3.1. Injectable
        • 5.2.3.2. Infusible
        • 5.2.3.3. Others
      • 5.2.4. Global Pharmaceutical Retail Chain by: Offerings (Value)
        • 5.2.4.1. Ambulatory Care
        • 5.2.4.2. Critical Care Pharmacy
        • 5.2.4.3. Nutrition Support Pharmacy
        • 5.2.4.4. Others
      • 5.2.5. Global Pharmaceutical Retail Chain Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Pharmaceutical Retail Chain (Price)
      • 5.3.1. Global Pharmaceutical Retail Chain by: Type (Price)
  • 6. Pharmaceutical Retail Chain: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Walgreens Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. CVS Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Walmart (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Rite Aid Corp (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. WALGREENS BOOTS ALLIANCE (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Fortis Healthworld (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. The Kroger (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Humana Pharmacy Solutions (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Botanics (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Liz Earle (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pharmaceutical Retail Chain Sale, by Type, Services, Medication, Offerings and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Retail Chain (Value)
      • 7.2.1. Global Pharmaceutical Retail Chain by: Type (Value)
        • 7.2.1.1. Retail Pharmacy
        • 7.2.1.2. Hospital Pharmacy
        • 7.2.1.3. Clinic Pharmacy
        • 7.2.1.4. Home care Pharmacy
        • 7.2.1.5. Others
      • 7.2.2. Global Pharmaceutical Retail Chain by: Services (Value)
        • 7.2.2.1. App/Website
        • 7.2.2.2. On-Call
      • 7.2.3. Global Pharmaceutical Retail Chain by: Medication (Value)
        • 7.2.3.1. Injectable
        • 7.2.3.2. Infusible
        • 7.2.3.3. Others
      • 7.2.4. Global Pharmaceutical Retail Chain by: Offerings (Value)
        • 7.2.4.1. Ambulatory Care
        • 7.2.4.2. Critical Care Pharmacy
        • 7.2.4.3. Nutrition Support Pharmacy
        • 7.2.4.4. Others
      • 7.2.5. Global Pharmaceutical Retail Chain Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Pharmaceutical Retail Chain (Price)
      • 7.3.1. Global Pharmaceutical Retail Chain by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Retail Chain: by Type(USD Million)
  • Table 2. Pharmaceutical Retail Chain Retail Pharmacy , by Region USD Million (2016-2021)
  • Table 3. Pharmaceutical Retail Chain Hospital Pharmacy , by Region USD Million (2016-2021)
  • Table 4. Pharmaceutical Retail Chain Clinic Pharmacy , by Region USD Million (2016-2021)
  • Table 5. Pharmaceutical Retail Chain Home care Pharmacy , by Region USD Million (2016-2021)
  • Table 6. Pharmaceutical Retail Chain Others , by Region USD Million (2016-2021)
  • Table 7. Pharmaceutical Retail Chain: by Services(USD Million)
  • Table 8. Pharmaceutical Retail Chain App/Website , by Region USD Million (2016-2021)
  • Table 9. Pharmaceutical Retail Chain On-Call , by Region USD Million (2016-2021)
  • Table 10. Pharmaceutical Retail Chain: by Medication(USD Million)
  • Table 11. Pharmaceutical Retail Chain Injectable , by Region USD Million (2016-2021)
  • Table 12. Pharmaceutical Retail Chain Infusible , by Region USD Million (2016-2021)
  • Table 13. Pharmaceutical Retail Chain Others , by Region USD Million (2016-2021)
  • Table 14. Pharmaceutical Retail Chain: by Offerings(USD Million)
  • Table 15. Pharmaceutical Retail Chain Ambulatory Care , by Region USD Million (2016-2021)
  • Table 16. Pharmaceutical Retail Chain Critical Care Pharmacy , by Region USD Million (2016-2021)
  • Table 17. Pharmaceutical Retail Chain Nutrition Support Pharmacy , by Region USD Million (2016-2021)
  • Table 18. Pharmaceutical Retail Chain Others , by Region USD Million (2016-2021)
  • Table 19. South America Pharmaceutical Retail Chain, by Country USD Million (2016-2021)
  • Table 20. South America Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 21. South America Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 22. South America Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 23. South America Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 24. Brazil Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 25. Brazil Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 26. Brazil Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 27. Brazil Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 28. Argentina Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 29. Argentina Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 30. Argentina Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 31. Argentina Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 32. Rest of South America Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 33. Rest of South America Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 34. Rest of South America Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 35. Rest of South America Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 36. Asia Pacific Pharmaceutical Retail Chain, by Country USD Million (2016-2021)
  • Table 37. Asia Pacific Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 38. Asia Pacific Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 39. Asia Pacific Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 40. Asia Pacific Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 41. China Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 42. China Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 43. China Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 44. China Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 45. Japan Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 46. Japan Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 47. Japan Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 48. Japan Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 49. India Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 50. India Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 51. India Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 52. India Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 53. South Korea Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 54. South Korea Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 55. South Korea Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 56. South Korea Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 57. Australia Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 58. Australia Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 59. Australia Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 60. Australia Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 61. Rest of Asia-Pacific Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 65. Europe Pharmaceutical Retail Chain, by Country USD Million (2016-2021)
  • Table 66. Europe Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 67. Europe Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 68. Europe Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 69. Europe Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 70. Germany Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 71. Germany Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 72. Germany Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 73. Germany Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 74. France Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 75. France Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 76. France Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 77. France Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 78. Italy Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 79. Italy Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 80. Italy Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 81. Italy Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 82. United Kingdom Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 83. United Kingdom Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 84. United Kingdom Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 85. United Kingdom Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 86. Netherlands Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 87. Netherlands Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 88. Netherlands Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 89. Netherlands Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 90. Rest of Europe Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 91. Rest of Europe Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 92. Rest of Europe Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 93. Rest of Europe Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 94. MEA Pharmaceutical Retail Chain, by Country USD Million (2016-2021)
  • Table 95. MEA Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 96. MEA Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 97. MEA Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 98. MEA Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 99. Middle East Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 100. Middle East Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 101. Middle East Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 102. Middle East Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 103. Africa Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 104. Africa Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 105. Africa Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 106. Africa Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 107. North America Pharmaceutical Retail Chain, by Country USD Million (2016-2021)
  • Table 108. North America Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 109. North America Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 110. North America Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 111. North America Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 112. United States Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 113. United States Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 114. United States Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 115. United States Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 116. Canada Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 117. Canada Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 118. Canada Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 119. Canada Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 120. Mexico Pharmaceutical Retail Chain, by Type USD Million (2016-2021)
  • Table 121. Mexico Pharmaceutical Retail Chain, by Services USD Million (2016-2021)
  • Table 122. Mexico Pharmaceutical Retail Chain, by Medication USD Million (2016-2021)
  • Table 123. Mexico Pharmaceutical Retail Chain, by Offerings USD Million (2016-2021)
  • Table 124. Pharmaceutical Retail Chain: by Type(USD/Units)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Pharmaceutical Retail Chain: by Type(USD Million)
  • Table 136. Pharmaceutical Retail Chain Retail Pharmacy , by Region USD Million (2022-2027)
  • Table 137. Pharmaceutical Retail Chain Hospital Pharmacy , by Region USD Million (2022-2027)
  • Table 138. Pharmaceutical Retail Chain Clinic Pharmacy , by Region USD Million (2022-2027)
  • Table 139. Pharmaceutical Retail Chain Home care Pharmacy , by Region USD Million (2022-2027)
  • Table 140. Pharmaceutical Retail Chain Others , by Region USD Million (2022-2027)
  • Table 141. Pharmaceutical Retail Chain: by Services(USD Million)
  • Table 142. Pharmaceutical Retail Chain App/Website , by Region USD Million (2022-2027)
  • Table 143. Pharmaceutical Retail Chain On-Call , by Region USD Million (2022-2027)
  • Table 144. Pharmaceutical Retail Chain: by Medication(USD Million)
  • Table 145. Pharmaceutical Retail Chain Injectable , by Region USD Million (2022-2027)
  • Table 146. Pharmaceutical Retail Chain Infusible , by Region USD Million (2022-2027)
  • Table 147. Pharmaceutical Retail Chain Others , by Region USD Million (2022-2027)
  • Table 148. Pharmaceutical Retail Chain: by Offerings(USD Million)
  • Table 149. Pharmaceutical Retail Chain Ambulatory Care , by Region USD Million (2022-2027)
  • Table 150. Pharmaceutical Retail Chain Critical Care Pharmacy , by Region USD Million (2022-2027)
  • Table 151. Pharmaceutical Retail Chain Nutrition Support Pharmacy , by Region USD Million (2022-2027)
  • Table 152. Pharmaceutical Retail Chain Others , by Region USD Million (2022-2027)
  • Table 153. South America Pharmaceutical Retail Chain, by Country USD Million (2022-2027)
  • Table 154. South America Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 155. South America Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 156. South America Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 157. South America Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 158. Brazil Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 159. Brazil Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 160. Brazil Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 161. Brazil Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 162. Argentina Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 163. Argentina Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 164. Argentina Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 165. Argentina Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 166. Rest of South America Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 167. Rest of South America Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 168. Rest of South America Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 169. Rest of South America Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 170. Asia Pacific Pharmaceutical Retail Chain, by Country USD Million (2022-2027)
  • Table 171. Asia Pacific Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 172. Asia Pacific Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 173. Asia Pacific Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 174. Asia Pacific Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 175. China Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 176. China Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 177. China Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 178. China Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 179. Japan Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 180. Japan Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 181. Japan Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 182. Japan Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 183. India Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 184. India Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 185. India Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 186. India Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 187. South Korea Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 188. South Korea Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 189. South Korea Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 190. South Korea Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 191. Australia Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 192. Australia Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 193. Australia Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 194. Australia Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 195. Rest of Asia-Pacific Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 196. Rest of Asia-Pacific Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 197. Rest of Asia-Pacific Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 198. Rest of Asia-Pacific Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 199. Europe Pharmaceutical Retail Chain, by Country USD Million (2022-2027)
  • Table 200. Europe Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 201. Europe Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 202. Europe Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 203. Europe Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 204. Germany Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 205. Germany Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 206. Germany Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 207. Germany Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 208. France Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 209. France Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 210. France Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 211. France Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 212. Italy Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 213. Italy Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 214. Italy Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 215. Italy Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 216. United Kingdom Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 217. United Kingdom Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 218. United Kingdom Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 219. United Kingdom Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 220. Netherlands Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 221. Netherlands Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 222. Netherlands Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 223. Netherlands Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 224. Rest of Europe Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 225. Rest of Europe Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 226. Rest of Europe Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 227. Rest of Europe Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 228. MEA Pharmaceutical Retail Chain, by Country USD Million (2022-2027)
  • Table 229. MEA Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 230. MEA Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 231. MEA Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 232. MEA Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 233. Middle East Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 234. Middle East Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 235. Middle East Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 236. Middle East Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 237. Africa Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 238. Africa Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 239. Africa Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 240. Africa Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 241. North America Pharmaceutical Retail Chain, by Country USD Million (2022-2027)
  • Table 242. North America Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 243. North America Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 244. North America Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 245. North America Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 246. United States Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 247. United States Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 248. United States Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 249. United States Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 250. Canada Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 251. Canada Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 252. Canada Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 253. Canada Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 254. Mexico Pharmaceutical Retail Chain, by Type USD Million (2022-2027)
  • Table 255. Mexico Pharmaceutical Retail Chain, by Services USD Million (2022-2027)
  • Table 256. Mexico Pharmaceutical Retail Chain, by Medication USD Million (2022-2027)
  • Table 257. Mexico Pharmaceutical Retail Chain, by Offerings USD Million (2022-2027)
  • Table 258. Pharmaceutical Retail Chain: by Type(USD/Units)
  • Table 259. Research Programs/Design for This Report
  • Table 260. Key Data Information from Secondary Sources
  • Table 261. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Retail Chain: by Type USD Million (2016-2021)
  • Figure 5. Global Pharmaceutical Retail Chain: by Services USD Million (2016-2021)
  • Figure 6. Global Pharmaceutical Retail Chain: by Medication USD Million (2016-2021)
  • Figure 7. Global Pharmaceutical Retail Chain: by Offerings USD Million (2016-2021)
  • Figure 8. South America Pharmaceutical Retail Chain Share (%), by Country
  • Figure 9. Asia Pacific Pharmaceutical Retail Chain Share (%), by Country
  • Figure 10. Europe Pharmaceutical Retail Chain Share (%), by Country
  • Figure 11. MEA Pharmaceutical Retail Chain Share (%), by Country
  • Figure 12. North America Pharmaceutical Retail Chain Share (%), by Country
  • Figure 13. Global Pharmaceutical Retail Chain: by Type USD/Units (2016-2021)
  • Figure 14. Global Pharmaceutical Retail Chain share by Players 2021 (%)
  • Figure 15. Global Pharmaceutical Retail Chain share by Players (Top 3) 2021(%)
  • Figure 16. Global Pharmaceutical Retail Chain share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Walgreens Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Walgreens Company (United States) Revenue: by Geography 2021
  • Figure 20. CVS Health (United States) Revenue, Net Income and Gross profit
  • Figure 21. CVS Health (United States) Revenue: by Geography 2021
  • Figure 22. Walmart (United States) Revenue, Net Income and Gross profit
  • Figure 23. Walmart (United States) Revenue: by Geography 2021
  • Figure 24. Rite Aid Corp (United States) Revenue, Net Income and Gross profit
  • Figure 25. Rite Aid Corp (United States) Revenue: by Geography 2021
  • Figure 26. WALGREENS BOOTS ALLIANCE (United States) Revenue, Net Income and Gross profit
  • Figure 27. WALGREENS BOOTS ALLIANCE (United States) Revenue: by Geography 2021
  • Figure 28. Fortis Healthworld (India) Revenue, Net Income and Gross profit
  • Figure 29. Fortis Healthworld (India) Revenue: by Geography 2021
  • Figure 30. The Kroger (United States) Revenue, Net Income and Gross profit
  • Figure 31. The Kroger (United States) Revenue: by Geography 2021
  • Figure 32. Humana Pharmacy Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 33. Humana Pharmacy Solutions (United States) Revenue: by Geography 2021
  • Figure 34. Botanics (India) Revenue, Net Income and Gross profit
  • Figure 35. Botanics (India) Revenue: by Geography 2021
  • Figure 36. Liz Earle (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 37. Liz Earle (United Kingdom) Revenue: by Geography 2021
  • Figure 38. Global Pharmaceutical Retail Chain: by Type USD Million (2022-2027)
  • Figure 39. Global Pharmaceutical Retail Chain: by Services USD Million (2022-2027)
  • Figure 40. Global Pharmaceutical Retail Chain: by Medication USD Million (2022-2027)
  • Figure 41. Global Pharmaceutical Retail Chain: by Offerings USD Million (2022-2027)
  • Figure 42. South America Pharmaceutical Retail Chain Share (%), by Country
  • Figure 43. Asia Pacific Pharmaceutical Retail Chain Share (%), by Country
  • Figure 44. Europe Pharmaceutical Retail Chain Share (%), by Country
  • Figure 45. MEA Pharmaceutical Retail Chain Share (%), by Country
  • Figure 46. North America Pharmaceutical Retail Chain Share (%), by Country
  • Figure 47. Global Pharmaceutical Retail Chain: by Type USD/Units (2022-2027)
Some of the key companies/manufacturers profiled in the report
  • Walgreens Company (United States)
  • CVS Health (United States)
  • Walmart (United States)
  • Rite Aid Corp (United States)
  • WALGREENS BOOTS ALLIANCE (United States)
  • Fortis Healthworld (India)
  • The Kroger (United States)
  • Humana Pharmacy Solutions (United States)
  • Botanics (India)
  • Liz Earle (United Kingdom)
Additional players considered in the study are as follows:
Kaiser Permanente (United States) , Rite Aid Corporation (United States) , Cigna/Express Scripts (United States) , Deep Healthcare Enterprises (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation